{
  "created_at": "2019-12-23T21:59:55.000Z",
  "updated_at": "2021-01-06T08:24:47.333Z",
  "id": "ed96b327-d297-4693-b476-3cac75b2372e",
  "labels": "current-affairs,2019-12-24",
  "question": "In light of launch of the Typhoid Conjugate vaccine/ TCV by Pakistan, consider the following statements:<br />\n<ol>\n<li>Pakistan is the first country to launch TCV.</li>\n<li>It is used to tackle Salmonella infection.</li>\n</ol>\nWhich of the above statements is/are true?",
  "option1": "Only 1 is correct",
  "option2": "Only 2 is correct",
  "option3": "Neither 1 nor 2 is correct",
  "option4": "Both 1 and 2 are correct",
  "option5": "",
  "answer": "Both 1 and 2 are correct",
  "explanation": "<strong>Statement 1 is correct:</strong>\nIn November, Pakistan became the first country to launch the TCV. The Typhoid Conjugate Vaccine was recommended and approved by WHO. The vaccine is to be used as part of routine immunisation program of the country as an intramuscular injection.\nÂ <strong>Statement 2 is correct:</strong>\nThe TCV is used to tackle a superbug strain of Salmonella called <em>S. typhi</em>. It is responsible for affecting about 11,000 people in Pakistan. It caused the death rate to increase by 20%. The Sindh province, which is the most affected, is to get the first leg of the immunisation campaign."
}